Search clinical trials for: TP-0903

Total 470 results

Sumitomo Pharma America, Inc.

Terminated

Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | SLL

United States
Sumitomo Pharma America, Inc.

Completed

First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors

Advanced Solid Tumors | Recurrent Ovarian Carcinoma | Colorectal Carcinoma | EGFR Positive Non-small Cell Lung Cancer | BRAF-Mutated Melanoma

United States
Uma Borate
Sumitomo Pharma Oncology, Inc.

Completed

TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia

Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia

United States
Emory University
Cooperative for Assistance and Relief Everywhere, Inc. (CARE)

Completed

Preventing Early Child Marriage in Nepal

Child Marriage

Nepal
Tarsus Pharmaceuticals, Inc.

Completed

Study to Evaluate the Food Effect of TP-05 in Healthy Participants

Healthy

United States
International Centre for Diarrhoeal Disease Research...
CARE Bangladesh; Gram Bikash Kendra (GBK); CARE USA

Recruiting

Evaluation of Tipping Point

Child Marriage

Bangladesh
Sumitomo Pharma America, Inc.

Terminated

Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors

Sarcoma | Ewing Sarcoma | Advanced Solid Tumors | Synovial Sarcoma | Dedifferentiated Liposarcoma

United States
St George's, University of London
Neovii Biotech

Withdrawn

Trial of Erythrocyte Encapsulated Thymidine Phosphorylase In Mitochondrial Neurogastrointestinal Encephalomyopathy (TEETPIM)

Mitochondrial Diseases | Inborn Errors of Metabolism | Metabolic Disease
Technophage, SA
VectorB2B

Not yet recruiting

Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia (RECOVER)

Pneumonia, Ventilator-Associated

France
Sumitomo Pharma America, Inc.

Terminated

A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS

Anemia in Myelodysplastic Syndromes

United States
Sumitomo Pharma America, Inc.

Recruiting

Phase 1 Study of Oral TP-1454

Advanced Solid Tumor | Anal Cancer

United States
Tarsus Pharmaceuticals, Inc.

Completed

Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis (Saturn-2)

Blepharitis

United States
National Taiwan University Hospital

Unknown

Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal Cancer

Esophageal Cancer

Taiwan
Theravance Biopharma

Completed

TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation

Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)

United States
Theravance Biopharma

Completed

First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19

Acute Lung Injury (ALI) Associated With COVID-19 | Inflammatory Lung Conditions Associated With COVID-19

United Kingdom
Sumitomo Pharma America, Inc.

Recruiting

A Study of Oral TP-3654 in Patients With Myelofibrosis

Myelofibrosis

United States, Japan, Australia
Sumitomo Pharma America, Inc.

Completed

Study of TP-3654 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Sumitomo Pharma America, Inc.

Completed

First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
Aljazeera Hospital
Cairo University

Completed

Evaluation of TP US in Women With Prolapse

Prolapse

Egypt
Universitat Jaume I

Not yet recruiting

Efficacy of a Transdiagnostic Group Treatment for Emotional Disorders Applied in Blended Format: a Controlled Study.

Anxiety Disorders | Depressive Disorders
Tetraphase Pharmaceuticals, Inc.

Completed

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects

End Stage Renal Disease
Tarsus Pharmaceuticals, Inc.

Active, not recruiting

A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05

Healthy Volunteer

United States
Tarsus Pharmaceuticals, Inc.

Completed

Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD (Ersa)

Meibomian Gland Dysfunction | Blepharitis | Demodex Infestation

United States
Aljazeera Hospital
Kasr El Aini Hospital

Unknown

Evaluation of Labour Progress by PC Angle

Labour

Egypt
Tarsus Pharmaceuticals, Inc.

Completed

A Pharmacokinetic Study of TP-05 in Healthy Subjects

Healthy

United States
Dilara Aydin Tozlu

Not yet recruiting

The Effect of Video-Assisted Sudden Infant Death Syndrome Prevention Training Program and Counseling Practice on Mothers' Knowledge Level and Self-efficacy: Randomized Controlled Study

Sudden Infant Death
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Glioblastoma Multiforme
Hospital El Cruce

Completed

Ventilator-induced Lung Injury Vortex in Patients With SARS-CoV-2 (VILIVORTEX)

ARDS | Ventilator-Induced Lung Injury | Mechanical Ventilation Complication

Argentina
National Institute of Diabetes and Digestive and...

Completed

North American Study for the Treatment of Refractory Ascites (NASTRA)

Liver Cirrhosis | Ascites

United States, Canada
Tarsus Pharmaceuticals, Inc.

Completed

Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis (Saturn-1)

Blepharitis

United States
Hospital El Cruce

Completed

The Role of Morphological Phenotype in ARDS (MPARDS)

Respiratory Distress Syndrome, Adult

Argentina
MedMira Laboratories Inc.
Public Health Agency of Canada (PHAC)

Recruiting

Evaluation of the Sensitivity, Specificity, and Utility of the Reveal® TP (Syphilis) Antibody POCT

Syphilis | Syphilis Infection | Early Syphilis, Symptomatic

Canada
Technophage, SA
VectorB2B

Recruiting

Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection (REVERSE2)

Diabetic Foot Infection

United States, India
University of Alabama at Birmingham

Completed

Gait Training Combined With Behavioral Strategies for People With Stroke

Stroke | Gait, Hemiplegic | Behavior and Behavior Mechanisms

United States
Tetraphase Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271

Pneumonia

United States
Tetraphase Pharmaceuticals, Inc.

Completed

A Safety and PK Study of IV Eravacycline

Bacterial Infections

United States
Theravance Biopharma

Completed

TD-0903 for ALI Associated With COVID-19

Acute Lung Injury (ALI) Associated With COVID-19 | Lung Inflammation Associated With COVID-19

Moldova, Republic of, United Kingdom, United States, Brazil, Finland, Romania, Ukraine
Tianjin Medical University Cancer Institute and...

Recruiting

Neoadjuvant Chemotherapytreatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma | Neoadjuvant Chemotherapy

China
Albany Medical College

Recruiting

Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications (ProBE-PC)

Prostate Cancer | Infection | PSA

United States
Technophage, SA
VectorB2B

Completed

Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers (REVERSE)

Diabetic Foot Ulcer | Staphylococcus Aureus Infection | Pseudomonas Aeruginosa Infection | Acinetobacter Infection

Israel
Tetraphase Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study

Bacterial Infections

United States
Tetraphase Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 TP-271 Oral PK Single Ascending Dose Study

Bacterial Infections

United States
Tetraphase Pharmaceuticals, Inc.
Department of Health and Human Services

Completed

Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and Women (BAL)

Normal Drug Tolerance

United States
Tetraphase Pharmaceuticals, Inc.

Completed

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects

Impaired Hepatic Function

United States
Tetraphase Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase 1 Safety and PK Study of IV TP-271

Bacterial Infections

United States
JW Pharmaceutical

Completed

Therapeutic Exploratory Study of CWP-0403

Type 2 Diabetes Mellitus

Korea, Republic of
Ocular Therapeutix, Inc.

Completed

A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert

Open Angle Glaucoma and Ocular Hypertension

United States
Hebei Tumor Hospital

Unknown

Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer

Lung Cancer

China
Rutgers, The State University of New Jersey
Colorado Department of Public Health and Environment; University of New Mexico

Completed

Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project (GRACE)

Breast Cancer | Ovarian Cancer

United States
Cancer Institute and Hospital, Chinese Academy...

Completed

Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer

Breast Cancer

China

Search clinical trials for: TP-0903

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations